ABP Company Profile and Key Details

Abpro Corporation (NASDAQ:ABP) closed at $1.67 USD, gaining $0.15 (9.87%) from the previous close of $1.52. The stock is currently mid-range between its 52-week high and low $1.44 and $34.65. With a market capitalization of about $3.38 million, Abpro Corporation is classified as a micro-cap and shows lower-than-market volatility (beta ~-0.00). Key stats such as the average daily volume over the past year has been around 225.33 thousand shares, trading with heavier-than-usual volume. Headquartered in Woburn, MA, Abpro Corporation operates in the Healthcare sector and the Biotechnology industry. Led by CEO Jin Wook Suk, the company employs approximately 6 people and listed since March 09, 2022. Abpro Holdings, Inc., a biotechnology company, engages in developing antibody therapeutics for patients with immuno-oncology, ophthalmology, and autoimmunity issues.

ABP has shown weak momentum, losing -21.17% over the past week and -45.68% over the past quarter, though year-to-date performance is down -26.95%. Short-term trend indicators are bullishly aligned (SMA20 -40.75%, SMA50 -63.35%, SMA200 -74.88%). The stock’s 14-day RSI is 22.0 (weak momentum), while the ATR of 0.36 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -95.61% below its high and over 5.56% above its low. Average 10-day trading volume of 10.74 million shares is significantly above the 3-month average of 1.24 million, indicating heightened recent market interest.

Analyst sentiment is bullish. Analyst rating data shows there are 0 Strong Buy ratings, 1 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $4.00 to $4.00. The high target offers 139.52% upside. The low target suggests 139.52% downside. The mean target is $4.00. This offers 139.52% upside. Abpro Corporation earnings surprise history is a mixed track record. The quarter that ended November 14, 2025, missed forecasts by -47.5%.

Abpro Corporation has 2.72 million shares outstanding. The public float is 1.73 million shares, elevated short interest at 0.28% of float. This equals 4.91 thousand shares. The short ratio is 0.42 days. Institutional investors hold 4.52% of the float. Insiders own 34.93%.

Abpro Corporation last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.08. This means the shares are trading below this model’s fair value.

Abpro Corporation trades at a P/E ratio of -0.32, slightly below the S&P 500 average, with a price-to-sales ratio of 18.73 and a price-to-book ratio of -0.27 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.25, also above market averages.

Abpro Corporation (NASDAQ:ABP) shares are down -26.95% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Abpro Corporation trading at a premium to the broader market with a P/E of -0.32. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $4.00, suggesting 139.52% upside. Our AI forecast model points to short-term weakness (-95.21% over two weeks), a medium-term rise (578.44% over three months), and a longer-term loss (-47.9% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Abpro Corporation stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -95.21%, with price expected at $0.08 by February 23, 2026, within a range of $0.00 to $0.35 3-Month Outlook: Projected rise of 578.44%, reaching $11.33 by May 08, 2026, with a range of $9.29 to $12.70. 1-Year Outlook: Projected loss of -47.9%, with price at $0.87 by February 09, 2027, within a range of $0.00 to $2.23.